Recent ELAN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:39:20 PM
- Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market • PR Newswire (US) • 05/18/2026 11:27:00 AM
- Elanco to Participate in Upcoming Investor Conferences • PR Newswire (US) • 05/14/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 01:34:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 01:04:17 PM
- Elanco (ELAN) shares climb after strong quarterly results and higher full-year outlook • IH Market News • 05/06/2026 12:12:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 10:30:14 AM
- Elanco Animal Health Reports First Quarter 2026 Results • PR Newswire (US) • 05/06/2026 10:27:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:12:55 PM
- /C O R R E C T I O N -- Elanco Animal Health/ • PR Newswire (US) • 04/28/2026 11:03:00 PM
- Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock • PR Newswire (US) • 04/27/2026 10:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 08:29:34 PM
- Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement • PR Newswire (US) • 04/16/2026 12:00:00 PM
- Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* • PR Newswire (US) • 04/09/2026 12:27:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 02:14:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/08/2026 02:07:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 09:19:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 08:43:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:15:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:14:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:21:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:19:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:15:49 PM
